![Gregory Challis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Leonard Challis has held the title of Chief Scientific Officer at Erebagen Ltd. since its founding in 2020.
Dr. Challis is the founder of Erebagen Ltd.
| Unternehmen | Position | Beginn |
|---|---|---|
Erebagen Ltd.
 Erebagen Ltd. BiotechnologyHealth Technology Develops novel bioactive products from microbes by activating previously silent gene clusters | Gründer | 30.03.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 1 |
|---|---|
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Develops novel bioactive products from microbes by activating previously silent gene clusters | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
